Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?

@article{Fergusson2005RandomizedCT,
  title={Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?},
  author={D. Fergusson and K. Glass and B. Hutton and S. Shapiro},
  journal={Clinical Trials},
  year={2005},
  volume={2},
  pages={218 - 232}
}
Background Aprotinin is a serine protease inhibitor used to limit perioperative bleeding and reduce the need for donated blood transfusions during cardiac surgery. Randomized controlled trials of aprotinin evaluating its effect on the outcome of perioperative transfusion have been published since 1987, and systematic reviews were conducted in 1992 and 1997. Methods A systematic search was conducted for all RCTs of aprotinin that used placebo controls or were open-label with no active control… Expand
147 Citations
Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
  • 46
Aprotinin: 1 year on
  • W. Dietrich
  • Medicine
  • Current opinion in anaesthesiology
  • 2009
  • 19
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
  • 982
  • PDF
Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: no
  • 18
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 100 REFERENCES
Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding.
  • 238
Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial.
  • 67
[Comparison between low and high doses of aprotinin in heart surgery].
  • 7
Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
  • 14
...
1
2
3
4
5
...